Of interest, HtrA2/Omi can play dual roles in mammalian cells, acting not only to induce apoptosis under cellular stress, but also to maintain mitochondrial homeostasis under normal condition.
46 Indeed, several caspase-independent death effectors including apoptosis-inducing factor, endonuclease G, and the HtrA2/Omi serine protease are released from the mitochondrial intermembrane space on permeabilization of the outer membrane.
40 Such proteins also have important roles in cellular redox metabolism and/or mitochondrial biogenesis. As a general rule, it thus appears that cell-death-relevant proteins, especially those involved in the core of the apoptosis-executing machinery, have a dual function in life and death. On induction of apoptosis,
HtrA2/Omi is released into the cytosol where it promotes cell death.
28 47 On the other hand, HtrA2/Omi has been shown to play a protective role against stress in neurons,
48 49 and a loss of function mutation in the gene encoding HtrA2/Omi is reported in human Parkinson disease.
50 Given the role of mitochondrial integrity in apoptosis, paradoxically, under nonstress conditions, the inhibition of HtrA2/Omi may actually enhance susceptibility to apoptosis and may explain the increased degeneration of striatal neurons in
HtrA2/
Omi − / − mice.
32 These mice allow us to examine the direct effect of
HtrA2/
Omi gene on ocular tissues. We found abnormal mitochondria in
HtrA2/
Omi − / − retina, a similar observation in the substantia nigra of these mice.
32 It is possible that HtrA2/Omi protease is essential for the maintenance of mitochondrial function in normal cells not committed to apoptosis. Indeed, we documented loss and abnormal mitochondria in human AMD eyes.
51 Taken together, these findings suggest that HtrA2/Omi has a complex role in cell death; under normal conditions HtrA2/Omi expression may be beneficial in mitochondrial integrity; however, under oxidative stress, enhanced HtrA2/Omi expression may become harmful to mitochondrial activity. The precise characterization of HtrA2/Omi-induced cell death requires further evaluation in more physiological and pathologic conditions.